Clinical and Translational Radiation Oncology
Издатель: Elsevier · ISSN 2405-6308 · 83 статей
- Integrating submandibular gland transfer with proton therapy to preserve salivary function
- European lung cancer congress 2026 – the thoracic radiation oncologist's view.
- Patient-reported outcomes in studies of STereotactic arrhythmia Radioablation for ventricular tachycardia (PRO-STAR) – A scoping review on behalf of the STOPSTORM.Eu consortium
- Comment on “Is rectal preparation necessary in contemporary image-guided prostate radiotherapy?”
- ESTRO guideline on radiotherapy in Merkel cell carcinoma
- Systematic review of short course radiation therapy with dose escalation for rectal cancer
- Quantitative dosimetric analysis of patterns of local recurrence after IMRT for primary undifferentiated pleomorphic sarcoma of the extremity
- Reply to Miszczyk et al. ‘focal therapy for prostate Cancer: is the “best available evidence” good enough?
- Prostate and pelvic SABR with or without a focal boost: results from a multicenter phase II prospective clinical trial
- Acute breast edema during 5-fraction ultra-hypofractionated radiotherapy after breast-conserving surgery: A cone-beam CT based evaluation
- Discordance between clinician- and patient-reported outcomes during radiotherapy for brain metastases: the prospective NeuroPRO study
- Validation and refinement of the N classification for nasopharyngeal carcinoma based on the 9th version AJCC/UICC TNM staging system in non-endemic regions of China: a multicenter cohort study
- PACTUS: A two-week radiotherapy regimen for patients with anal squamous cell carcinoma unsuitable for standard chemoradiotherapy—a retrospective single-centre experience
- Hypofractionated and stereotactic body proton radiotherapy for a high-risk lung cancer cohort: A multi-institutional experience from the proton collaborative group prospective registry
- Patterns and predictors of intrafractional tumor displacement assessed by pre- and post-treatment CBCT during end-exhalation breath-hold lung stereotactic body radiation therapy
- Daily adaptive 1.5 T MR-Linac image-guided re-irradiation for prostate cancer: an international retrospective experience
- Friday again: Timing and referral patterns of acute radiotherapy in a tertiary supraregional care network
- “Clinical outcomes of definitive interstitial/hybrid high-dose-rate and pulsed-dose-rate interventional radiotherapy (brachytherapy) for non-melanoma skin cancer: A single-center retrospective analysis”
- Rapid response MR-guided radiotherapy for single fraction metastatic cord compression (MSCC) treatment (RESONATE): A study protocol
- Impact of residual suspicious lymph nodes after axillary lymph node dissection and radiotherapy in breast cancer patients
- Ablative magnetic resonance–guided radiation for gastrointestinal neuroendocrine tumors: assessing local control and toxicity
- CyberKnife SBRT plus lenvatinib and tislelizumab versus doublet systemic therapy for hepatocellular carcinoma with macrovascular invasion: A real-world IPTW-adjusted study
- Surgery followed by adjuvant radiotherapy versus definitive radiotherapy for locally advanced squamous cell carcinoma of the pharynx and larynx: a propensity score-matched analysis
- 36.25 Gy versus 40 Gy in five fractions of curative stereotactic body radiotherapy for prostate cancer: a propensity score-matched analysis
- MR-guided ultra-hypofractionated radiotherapy for early-stage glottic cancer: A phase I feasibility study
- The value of community engagement in the ESTRO–EORTC OligoCare project: A quantification of the in-kind contributions
- Prolonging breath-hold duration in radiotherapy using cognitive engagement
- Effects of rectal retractor use on dosimetric parameters, treatment-related adverse events, and clinical outcomes of cervical cancer brachytherapy: A retrospective tertiary-centre study
- Evaluation of the nutritional and digestive impact of irradiation in nasopharyngeal cancers: the French multicenter retrospective DRAKAR study
- Feasibility and potential benefits of daily online adaptive radiotherapy for head and neck cancer without margin reduction using an RTT-only workflow